DRKS00023177RecruitingNot Applicable
Therapeutic Targeting of Lyn Kinase To Treat Chorea-Acanthocytosis - an observational, non-interventional study
Sektion für Translationale Neurodegeneration Albrecht KosselKlinik und Poliklinik für NeurologieUniversitätsmedizin Rostock0 sites10 target enrollmentStarted: October 5, 2020Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 10
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to 99 Years (—)
- Sex
- All
Inclusion Criteria
- •Patients suffering from chorea-acanthocytosis (confirmed by chorein western blot and/or genetic testin), off-label therapy with Dasatinib or Nilotinib
Exclusion Criteria
- •not applicable
Investigators
Similar Trials
Recruiting
Not Applicable
Therapeutic Targeting of Lyn Kinase with Nilotinib to Treat Chorea-Acanthocytosis - an observational, non-interventional studyG23.9Degenerative disease of basal ganglia, unspecifiedDRKS00024187Sektion für Translationale Neurodegeneration Albrecht KosselKlinik und Poliklinik für NeurologieUniversitätsmedizin Rostock10
Unknown
Not Applicable
Tyrosine Kinase Inhibitor for the Treatment of Severe Pulmonary Arterial Hypertensiopulmonary arterial hypertensionJPRN-UMIN000001578Medical Education Center10
Active, not recruiting
Phase 1
A muulticenter study to evaluate drug response for the treatment of a white blood cell cancer in early chronic phaseEUCTR2011-002787-25-ITG.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL'ADULTO120
Active, not recruiting
Not Applicable
A multicenter study to evaluate drug response for the treatment of a white blood cell cancer in early chronic phase.EUCTR2007-000597-22-ITG.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL'ADULTO
Not yet recruiting
Phase 1
Effect of acupuncture on the Myofascial trigger point of pain in patients with knee osteoarthritisKnee osteoarthritisITMCTR2000004098Huadong Hospital affiliated to Fudan University